Table 1:
Baseline characteristics of CS-STEMI patients with and without bleeding complications, acute limb ischemia and stroke.
| CS with STEMI | Total Bleeding Complications | Acute Limb Ischemia | ||||
|---|---|---|---|---|---|---|
| Yes | No | P-value | Yes | No | P-value | |
| No. of observations(weighted) | 31389 | 141102 | 1628 | 170863 | ||
| Age (in years) (Mean± SE) | 67.6 (±0.07) | 66.6 (±0.03) | <0.001 | 63.3 (±0.2) | 66.8 (±0.03) | <0.001 |
| Female | 41.8% | 35.2% | <0.001 | 42.0% | 36.3% | <0.001 |
| Race | <0.001 | <0.001 | ||||
| White | 74.4% | 78.6% | 78.1% | 77.8% | ||
| Black | 7.1% | 6.5% | 7.1% | 6.6% | ||
| Hispanic | 9.0% | 7.3% | 8.2% | 7.6% | ||
| Asian or Pacific Islander | 4.1% | 2.8% | 0.7% | 3.1% | ||
| Native American | 0.5% | 0.6% | 0% | 0.6% | ||
| Others | 4.8% | 4.2% | 6.0% | 4.3% | ||
| Chronic Medical Conditions (%) | ||||||
| Cardiac arrhythmia | 49.8% | 46.9% | <0.001 | 48.5% | 47..4% | 0.39 |
| Cardiac arrest | 20.0% | 20.9% | <0.001 | 24.3% | 20.7% | <0.001 |
| Hypertension | 55.3% | 51.1% | <0.001 | 43.4% | 52.0% | <0.001 |
| Chronic liver disease | 1.6% | 1.3% | <0.001 | 1.8% | 1.3% | 0.06 |
| Diabetes | 32.8% | 29.2% | <0.001 | 27.0% | 29.8% | 0.01 |
| Obesity | 10.7% | 9.5% | <0.001 | 9.3% | 9.7% | 0.62 |
| Dyslipidemia | 37.0% | 39.8% | <0.001 | 27.9% | 39.4% | <0.001 |
| Chronic pulmonary disease | 22.1% | 20.4% | <0.001 | 23.4% | 20.7% | 0.008 |
| Pulmonary Circulation disorder | 0.4% | 0.2% | <0.001 | 1.3% | 0.2% | <0.001 |
| Congestive Heart Failure | 4.8% | 2.3% | <0.001 | 6.0% | 2.7% | <0.001 |
| Anemia | 33.1% | 15.4% | <0.001 | 17.5% | 18.6% | 0.3 |
| Coagulopathy | 24.1% | 10.7% | <0.001 | 23.2% | 13.1% | <0.001 |
| Chronic Kidney Disease | 18.4% | 14.1% | <0.001 | 12.7% | 14.9% | 0.01 |
| Peripheral Vascular Disease | 13.0% | 9.5% | <0.001 | 73.0% | 9.5% | <0.001 |
| Alcohol abuse | 4.4% | 4.1% | 0.003 | 3.6% | 4.1% | 0.30 |
| h/o MI | 6.1% | 6.7% | <0.001 | 4.7% | 6.6% | 0.003 |
| h/o PCI | 7.7% | 7.9% | 0.5 | 6.5% | 7.9% | 0.055 |
| h/o CABG | 2.1% | 2.8% | <0.001 | 1.7% | 2.7% | 0.01 |
| Atrial fibrillation | 26% | 21.6% | <0.001 | 22.5% | 22.4% | 0.9 |
| h/o CVA | 4.6% | 4.5% | 0.6 | 4.1% | 4.5% | 0.5 |
| Elixhauser Comorbidities | <0.001 | <0.001 | ||||
| 0 | 5.4% | 10.9% | 3.1% | 10.0% | ||
| 1–3 | 55.1% | 65.2% | 52.6% | 63.5% | ||
| ≥4 | 39.5% | 23.9% | 44.3% | 26.5% | ||
| Revascularization Methods | ||||||
| CABG | 31.5% | 11.6% | <0.001 | 19.8% | 15.1% | <0.001 |
| PCI | 54.4% | 67.4% | <0.001 | 61.9% | 65.1% | <0.001 |
| Fibrinolytic therapy | 2.3% | 1.9% | <0.001 | 4.9% | 2.0% | <0.001 |
| Vasopressor use | 7.8% | 6.1% | <0.001 | 9.0% | 6.4% | <0.001 |
| Expected primary payer | <0.001 | <0.001 | ||||
| Medicare | 56.6% | 53.1% | 44.8% | 53.8% | ||
| Medicaid | 7.7% | 7.4% | 10.3% | 7.4% | ||
| Private | 26.8% | 28.9% | 34.6% | 28.4% | ||
| Others | 2.5% | 3.1% | 1.8% | 3.0% | ||
| Hospital bed size | <0.001 | 0.06 | ||||
| Small | 6.5% | 8.3% | 6.5% | 8.0% | ||
| Medium | 20.9% | 22.3% | 21.4% | 22.1% | ||
| Large | 72.5% | 68.3% | 72.1% | 69.9% | ||
| Hospital teaching status | <0.001 | <0.001 | ||||
| Rural | 4.4% | 6.9% | 3.3% | 6.4% | ||
| Urban, Non-teaching | 37.9% | 39.1% | 32.7% | 38.9% | ||
| Urban, teaching | 57.7% | 54.1% | 63.9% | 54.6% | ||